Curasight doses first patient in Phase I brain cancer trial of uTREAT
Denmark-based Curasight has dosed the first patient in the Phase I clinical trial of its uTREAT diagnostic platform, targeting high-grade …
Post
-
-
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system, …
-
EDX Medical plans UK bowel cancer testing service launch
EDX Medical is launching a bowel cancer testing service in the UK in the coming weeks that is intended to …
-
New report highlights challenges hampering hospital connected device security
A new survey by cybersecurity company Asimily has identified that persistent visibility gaps and internal process breakdowns are among the …
-
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody-related autism. The MAR-Autism Test is designed to detect …
-
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The US Food and Drug Administration (FDA) has granted 510(k) clearance to SleepRes’ Kairos positive airway pressure (KPAP)-powered Kricket PAP …
-
FDA clears CMR Surgical’s Versius Plus robot
CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system, …
-
Sanome to roll out AI infection detection tool in two UK hospitals
The UK’s Royal Hospital for Neuro-disability and the East Kent Hospitals University NHS Foundation Trust have tapped Sanome’s MEMORI platform …
-
Zimmer Biomet and OneStep to deliver digital mobility analytics in orthopaedics
Zimmer Biomet has entered an exclusive partnership with OneStep, a digital fall prevention and mobility intelligence platform, to deliver a …
-
Philips announces SpectraWAVE acquisition, expanding intravascular imaging portfolio
Philips has agreed to acquire SpectraWAVE, a Massachusetts-based medical device company focused on technologies to help diagnose and guide treatment …
-
Thermedical treats first patient in trial of SERF ablation system for VT
Thermedical has treated the first patient in a pivotal clinical trial of its saline-enhanced radiofrequency (SERF) ablation system, used in …
-
May Health gains CE mark for infertility treatment
France-headquartered May Health has secured a European CE mark for its Anavi system to address infertility in women with polycystic …
-
FDA removes patient-identifiable RWE requirement for device submissions
The US Food and Drug Administration (FDA) is removing a limitation on the use of real-world evidence (RWE), clearing the …
-
FDA approves Dilon’s intraoperative margin assessment device
The US Food and Drug Administration (FDA) has granted approval for Dilon Technologies’ MarginProbe 2, a next-generation intraoperative margin assessment …
-
Helio Genomics and LiverRight team up for early detection of liver cancer
Helio Genomics and LiverRight have entered a partnership to improve access to early liver cancer detection in the US. The collaboration …
